<DOC>
	<DOCNO>NCT01649713</DOCNO>
	<brief_summary>This yearly licence tolerability immunogenicity study Fluval AB suspension injection ( trivalent , seasonal influenza vaccine , active ingredient content : 15 μgHA/strain/0.5mL ) adult elderly subject assess immunogenicity single intramuscular injection Fluval AB suspension injection , measure haemagglutination inhibition ( HI ) test , evaluate safety tolerability ( incidence adverse event ) single intramuscular injection Fluval AB suspension injection .</brief_summary>
	<brief_title>Yearly Licence Tolerability Immunogenicity Study Fluval AB Seasonal Influenza Vaccine Used 2012/2013 Vaccination Season</brief_title>
	<detailed_description>For 2011-2012 vaccination season follow influenza virus strain recommend included influenza vaccine : - A/California/7/2009 ( H1N1 ) -like virus , - A/Perth/16/2009 ( H3N2 ) -like virus , - B/Brisbane/60/2008-like virus . For 2012-2013 season follow strain recommend ( Amended EU Recommendations Seasonal Influenza Vaccine Composition Season 2012/2013 , EMA/CHMP/BWP/140597/2012 ) : - A/California/7/2009 ( H1N1 ) -like virus , - A/Victoria/361/2011 ( H3N2 ) -like virus , - B/Wisconsin/1/2010-like virus . Since A/H3N2 B virus strain change , yearly licence clinical study perform .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adult person age 18 59 year , elderly person age ≥60 year sexes , mentally competent ; Are good health ( determine vital sign exist medical condition ) stable medical condition . Subjects exclude know adequately treat clinically significant organ systemic disease ( e.g . asthma diabetes ) , , opinion investigator , significance disease compromise subject 's participation study ; Female volunteer age 1859 year ( i.e . participant childbearing potential ) negative result urine pregnancy test prior vaccination agree use acceptable contraception method abstinence throughout trial become pregnant duration study . Capability participant understand comply plan study procedure ; Participants provide write informed consent prior initiation study procedure ; Absence existence exclusion criterion . Pregnancy , breast feeding positive urine pregnancy test baseline prior vaccination . Female subject able bear child willing use acceptable contraception method duration study . Known hypersensitivity egg , chicken protein , thiomersal , formaldehyde , gentamycin , ciprofloxacin , neomycin , vancomycin component vaccine ; History GuillainBarré syndrome ; History neurological symptom sign , anaphylactic shock follow administration vaccine ; Serious disease , cancer , autoimmune disease , advance arteriosclerotic disease , complicate diabetes mellitus , acute progressive hepatic disease , acute progressive renal disease , congestive heart failure ; Immunosuppressive therapy within 36 month prior vaccination ; Concomitant corticosteroid therapy , include highdose inhaled corticosteroid ; Receipt immunostimulants ; Receipt parenteral immunoglobulin , blood product and/or plasma derivate within 3 month prior vaccination ; Suspected known HIV , HBV HCV infection ; Acute disease and/or axillary temperature ≥37oC within 3 day prior vaccination ; Vaccine therapy within 4 week prior vaccination ; Influenza vaccination ( kind ) within 6 month prior vaccination ; Experimental drug therapy within 4 week prior vaccination ; Concomitant participation another clinical study ; Any condition , opinion investigator , may interfere evaluation study ; Past current psychiatric disease volunteer upon judgement investigator may effect objective decisionmaking volunteer ; Alcohol drug abuse participant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Fluval AB</keyword>
	<keyword>influenza</keyword>
	<keyword>vaccine</keyword>
	<keyword>immunization</keyword>
	<keyword>infection</keyword>
</DOC>